Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(171)
•••
Post by Sosak1on Oct 30, 2024 11:06am
232 Views
Post# 36288730

Compare volume when stock was going up and down in 6 days

Compare volume when stock was going up and down in 6 daysAlmoust 4 mil. in buying and 700 k in selling
2024-10-22 V TLT 0.345 0.37 0.25 0.365 -0.015 1,914,778 610 0.32 0.365 908,496 81,900 165,300 391,500 1,346 70,500 279,500     13,210      
2024-10-21 V TLT 0.19 0.38 0.19 0.38 0.19 1,368,119 245 0.265 0.38 935,593 74,000 147,118 91,000 200 13,500 99,500

 
2024-10-24 V TLT 0.315 0.35 0.29 0.35 0.03 432,887 169 0.31 0.35 165,057 21,500 70,000 46,500 920 79,500 34,000
 
2024-10-29 V TLT 0.26 0.26 0.25 0.255 -0.01 280,363 89 0.25 0.255 206,597 19,500 1,500 18,500 400 12,500 20,500     465      
2024-10-28 V TLT 0.28 0.285 0.26 0.26 -0.03 217,452 85 0.26 0.27 94,908 22,500 26,500 41,500 290   30,500     470      
2024-10-25 V TLT 0.34 0.34 0.26 0.265 -0.085 757,908 227 0.26 0.29 415,288 26,500 86,500 122,500 357 3,000 97,000
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities